Indeed, the Tie1‐specific antibody AB‐Tie1‐39 (which activates Tie2 in vivo) could protect mice from lung metastases when used in a neoadjuvant treatment setting before primary tumor resection (Singhal et al,2020). This evidence concerns the gene TIE1 and neoplasm.